Core Viewpoint - In October, A-shares maintained a high-level fluctuation, with the Shanghai Composite Index rising by 1.85%, while the Shenzhen Component Index and the ChiNext Index fell by 1.1% and 1.56% respectively. Despite this, 69% of the private equity products from billion-yuan private equity firms reached historical highs in net value, indicating resilience in certain investment strategies amidst market volatility [2][3][4]. Group 1: Market Performance - The overall trading volume in the A-share market shrank compared to previous months, reflecting a cautious market sentiment [2]. - Among billion-yuan private equity products, 407 products achieved historical net value highs, with quantitative products leading the way [2][3]. Group 2: Product Strategy and Performance - The majority of high-performing products were equity strategies, with 327 products, of which 201 were quantitative long strategies and 103 were subjective long strategies [2][3]. - 24 billion-yuan private equity firms had over 80% of their products reach historical highs, with 13 firms achieving 100% of their products hitting new highs [3][4]. Group 3: Notable Firms and Products - Notable firms such as Dongfang Gangwan and Jukun Investment had over 90% of their products reach historical highs, with Dongfang Gangwan leading with 77 out of 80 products achieving this milestone [4][9]. - The top-performing products over the past year were primarily from firms like Yuanxin Investment and Juku Investment, with significant returns attributed to investments in the AI sector [8][12]. Group 4: Long-term Performance - Over the past three years, macro strategy products from firms like Juku Investment and Honghu Private Equity dominated the top rankings, indicating a strong performance in this investment category [12][16]. - The five-year performance rankings were led by Honghu Private Equity and Jukun Investment, showcasing the effectiveness of their investment strategies over a longer horizon [16][19].

Core Viewpoint - The article discusses the performance of non-debt private equity products in the A-share market, highlighting those that have achieved consecutive positive returns over the years, indicating the fund managers' ability to navigate market fluctuations [2][10]. Summary by Sections 2023 Performance - In 2023, among private equity companies managing over 500 million, there were 1,731 non-debt private equity products, with 1,026 (59.27%) achieving consecutive positive returns [2]. - The threshold for the top 20 products in cumulative returns for 2023 was set at ***% [2]. - The majority of the top 20 products (15) were subjective long strategies, with only one product from a billion-dollar private equity firm, Oriental Harbor [2]. Top Products in 2023 - The top five products based on returns were managed by: - Qian Jun from Chiying Private Equity - Zhou Yifeng from Beiheng Fund - Chen Yongbao from Ding Tai Si Fang (Shenzhen) - Wu Gengxin from Zhun Jin Investment - Shi Hao from Shanghai Ge Ru Private Equity [3]. 2021 Performance - For the period from 2021, there were 855 non-debt private equity products, with 184 (21.52%) achieving consecutive positive returns [10]. - The threshold for the top 20 products in cumulative returns for 2021 was also set at ***% [10]. - Half of the top 20 products were subjective long strategies, with a notable presence of quantitative long products [10]. Top Products in 2021 - The top five products were managed by: - He Wenling from Qianhai Guoen Capital - Liu Zhiyong from Caoben Investment - Li Ting from Gongqingcheng Guangju Xinghe Private Equity - Ma Changhai from Hengbang Zhaofeng - Li Jiabin from Qianhai Haifu Asset [11]. 2019 Performance - In 2019, there were 377 non-debt private equity products, with 54 (14.32%) achieving consecutive positive returns [15]. - The threshold for the top 20 products in cumulative returns for 2019 was set at ***% [15]. - The top 20 products included seven subjective long products, with a mix of quantitative long, macro strategies, and composite strategies [15]. Top Products in 2019 - The top five products were managed by: - Yang Zhongxian from Jilu Asset - Chen Yu from Shennong Investment - Yao Qicong from Jiukun Investment - Liang Wentao from Honghu Private Equity - Yu Zilong from Shanghai Yuanlai Private Equity [16][22].

Core Insights - Quantitative investment has gained popularity among investors due to its rational, scientific, and emotionally stable characteristics. Jiukun Investment, one of the earliest quantitative private equity firms in China, has won over 150 industry awards and maintains competitive performance and scale [2][6]. Performance Metrics - As of the end of August, Jiukun Investment has 13 products with reported performance, achieving an average return of ***% this year. The "Jiukun Day Enjoy CSI 1000 Index Enhanced No. 1" product ranks first in returns this year, with a five-year excess return of ***% and a cumulative return of ***% since inception, showcasing Jiukun's strong long-term investment capabilities in the index enhancement sector [2][4]. AI Integration - With the rapid development of artificial intelligence, Jiukun Investment has positioned itself as a technology company from its inception, establishing an AI team early on and launching an internal lab in 2020. Over 90% of the researchers hired in the past five years have an AI research background, enabling comprehensive AI capability coverage in the investment research team [5][12]. Investment Principles - Jiukun Investment adheres to three core investment principles: "rationality, long-term focus, and scientific approach," which empower its quantitative investment strategies to create long-term value for investors [6][11]. Talent and Organizational Structure - The company emphasizes the importance of talent and organizational structure as core assets in the quantitative field. Jiukun has a diverse team of experts in mathematics, physics, and computer science, and it fosters a culture of free research and collaboration to enhance its research capabilities [10][15]. Long-term Strategy and Market Position - Jiukun Investment has been deeply involved in the quantitative field for over 13 years, accumulating extensive historical data and practical experience. This foundation allows the firm to quickly address new market challenges and develop robust index enhancement strategies, such as the recently launched A500 index enhancement product [16][17].

Core Viewpoint - Quantitative investment has gained popularity among investors due to its rational, scientific, and emotionally stable characteristics. Jiukun Investment, as one of the earliest quantitative private equity firms in China, has maintained a leading scale and performance competitiveness over the years, winning over 150 industry awards [2]. Group 1: Performance and Products - As of the end of August, Jiukun Investment has 13 products with reported performance, achieving an average return of ***% this year. The "Jiukun Daily Enjoyment CSI 1000 Index Enhanced No. 1" product ranks first in returns this year, with a five-year excess return of ***% and a cumulative return of ***% since inception, showcasing Jiukun's long-term investment capability in the index enhancement sector [2]. - Jiukun Investment has a well-established and mature framework for index enhancement strategies, with a team experienced in various sub-strategies. The firm has 13 products that reached historical highs in August [22][23]. Group 2: AI Integration and Research - Jiukun Investment has positioned itself as a technology company from its inception, establishing an AI team early on and forming an internal laboratory in 2020. Over the past five years, over 90% of the recruited researchers have an AI research background, enabling comprehensive AI capability coverage in quantitative investment [5][19]. - The firm emphasizes the importance of scientific methods and a keen sense of cutting-edge technology, which are core advantages that allow Jiukun to navigate cycles and continuously iterate [7][14]. Group 3: Investment Principles and Talent - Jiukun Investment adheres to three main investment principles: rationality, long-term focus, and scientific approach, which empower every aspect of quantitative investment [6][10]. - Talent organization is considered a core asset in the quantitative field. Jiukun has a diverse team of experts in mathematics, physics, and computer science, and emphasizes nurturing talent through various programs and competitions [20].

Core Viewpoint - The article emphasizes the performance of private equity funds in China's capital market, highlighting the challenges of maintaining top rankings over different time frames amidst market volatility [1]. Group 1: Subjective Long/Short Strategies - A total of 23 private equity products have ranked in the top 20% for short-term (January to August), medium-term (three years), and long-term (five years) performance [1]. - As of August 2025, there are 1,974 subjective long/short private equity products reported for this year, 1,353 for the last three years, and 760 for the last five years [1]. Group 2: Quantitative Long/Short Strategies - 21 products from quantitative long/short strategies have also ranked in the top 50% across all three performance periods [5]. - Among these, 11 products belong to large-scale quantitative private equity firms, indicating a strong presence in the market [5]. Group 3: Futures and Derivatives Strategies - 19 private equity products have achieved top 30% performance across short, medium, and long-term periods in the futures and derivatives category [8]. - As of August 2025, there are 678 products reported for this year, 403 for the last three years, and 162 for the last five years in this strategy [8]. Group 4: Multi-Asset Strategies - 18 multi-asset strategy products have ranked in the top 30% for all three performance periods [12]. - The article notes that large-scale private equity firms like Blackwing Asset and Duration Investment have products listed among the top performers [12]. Group 5: Market Outlook - The market is expected to experience fluctuations, with technology, pharmaceuticals, and new consumption identified as key investment areas for the next decade [4]. - The article mentions that the A-share market is likely to remain in a bullish phase, with significant opportunities in sectors like technology and healthcare [4].

Group 1 - The article emphasizes the importance of long-term performance in the capital market, highlighting that strategies need to be continuously learned and iterated to achieve sustained profits [1] - It categorizes private equity products into "long-distance running" types, focusing on those with outstanding performance over the past five years and those established for over ten years, referred to as "double ten funds" [1] - As of July 2025, there are 61 private equity products that have been established for ten years, with 32 of them achieving an annualized return of over 10%, accounting for approximately 52% [2] Group 2 - Among the "double ten funds," 14 products reached historical highs in July 2025, with 25 of them being subjective long/short products [2] - Notable private equity firms such as Evolutionary Assets, Shenzhen Yitong Investment, Tonghe Investment, and Zhongrui Huyin each have two products listed among the top performers [3] - The article provides a detailed table of various private equity products, including their strategies, sizes, and performance metrics, showcasing the diversity in the market [4][5] Group 3 - The subjective long/short product "Xi Wa Xiao Niu No. 1," managed by Liang Hong, was established near the peak of the last bull market and has shown significant returns [5][6] - Liang Hong expresses a preference for core companies that can be compared with international leaders, rather than supply chain stocks [6][7] - The article also discusses the performance of quantitative long/short products, noting that the average annualized return for these products over the past five years is 13.27% [12] Group 4 - The multi-asset strategy products have an average annualized return of 10.84% over the past five years, with several products reaching historical highs in July 2025 [16] - The article highlights the performance of bond strategy products, which have an average annualized return of 11.87% over the past five years, with many products achieving historical highs recently [24] - It concludes with a focus on the performance of futures and derivatives strategy products, which also show strong returns and historical highs [20]

Core Viewpoint - The article emphasizes the importance of long-term performance in private equity funds, highlighting that only a few funds can achieve consistent returns over extended periods, thus necessitating continuous learning and strategy iteration in the capital market [1]. Group 1: Long-term Private Equity Products - As of July 2025, there are 61 private equity products that have been established for over 10 years, with 32 of them achieving an annualized return of over 10%, representing approximately 52% of the total [2]. - Among these, 14 funds reached historical highs in July 2025, with subjective long/short products making up 25 of these funds [2]. Group 2: Performance of Specific Funds - The "Xiwa Little Bull No. 1" fund, managed by Liang Hong, was established on May 8, 2015, and has shown significant performance, with annualized returns nearing ***% and returns exceeding ***% this year [5]. - The article lists various funds and their strategies, including subjective long/short and macro strategies, with specific funds achieving notable returns and historical highs [3][4][6]. Group 3: Strategy Performance Rankings - For funds established for over 5 years, there are 1,303 products, with 32 achieving annualized returns exceeding ***% and 132 exceeding ***% [6]. - The top 20 funds in the subjective long/short category have an average annualized return of 9.2%, with the threshold for the top performers being over ***% [6][7]. Group 4: Quantitative and Multi-Asset Strategies - In the quantitative long/short category, 72 products have an average annualized return of 13.27%, with the top 20 funds achieving returns above ***% [13]. - Multi-asset strategy products have an average annualized return of 10.84%, with the top performers coming from firms like Qianhai Guoen Capital and Honghu Private Equity [17]. Group 5: Bond Strategy Performance - The bond strategy products have an average annualized return of 11.87%, with the top products achieving significant returns and historical highs [28].

Core Viewpoint - The article analyzes the performance of quantitative products in the A-share market from 2022 to 2024, highlighting that 39.38% of the 650 quantitative products achieved positive excess returns for three consecutive years, with a notable performance from large-scale private equity firms [2][5][6]. Group 1: Performance of Quantitative Products - In the past three years, the A-share market has experienced significant volatility, with the Shanghai Composite Index fluctuating between 2600 and 3600 points [2]. - Among the 650 quantitative products with performance data, 256 achieved positive excess returns for three consecutive years, representing approximately 39.38% [2][6]. - For large-scale private equity firms (over 10 billion), 179 quantitative products were tracked, with 114 achieving positive excess returns, resulting in a leading performance rate of 63.69% [6][7]. Group 2: Top Performing Private Equity Firms - The top private equity firms with the most quantitative products achieving positive excess returns over three years include JQData (31 products), Ningbo Huanfang (11 products), and Longqi Technology (9 products) [6][7]. - The top three products with the highest excess returns over the past three years are from Abama Investment, Jiukun Investment, and Maoyuan Quantitative [7][10]. Group 3: Performance by Scale of Private Equity - For private equity firms with assets between 50-100 billion, 51 quantitative products were tracked, with only 19 achieving positive excess returns, accounting for 37.25% [14]. - The leading firms in this category include Jun Cheng Asset Management (4 products) and He Fu Investment (2 products) [14][15]. - The top three products in this category are from Liang Kui Private Equity, Ping Fang He Investment, and Jun Cheng Asset Management [14]. Group 4: Performance in Smaller Private Equity Firms - In the 20-50 billion category, 88 quantitative products were tracked, with only 25 achieving positive excess returns, representing 28.41% [21]. - The leading firms include Junfu Investment and Youmeili Investment, each with 3 products achieving positive excess returns [21]. - The top three products in this category are from Qianhai Guoen Capital, Yuehai Yinghe Fund, and Junfu Investment [21]. Group 5: Performance in the Smallest Private Equity Firms - For private equity firms with assets between 0-5 billion, 196 quantitative products were tracked, with 46 achieving positive excess returns, accounting for 23.47% [41]. - The leading firms in this category include Mufeng Investment and Hongtong Investment, each with multiple products achieving positive excess returns [41]. - The top three products in this category are from Ruixin Tiansuan, Hainan Zhiyuan Private Equity, and Yitian Pavilion Asset Management [41].

Core Viewpoint - The article highlights the increasing integration of AI in quantitative private equity firms in China, showcasing the significant advancements and performance improvements achieved through AI technologies in investment strategies [2][5][9]. Group 1: Company Developments - NianKong Technology has collaborated with Shanghai Jiao Tong University to submit a research paper on large language models, indicating its commitment to AI research [2]. - The company has established Shanghai QuanPin Siwei Artificial Intelligence Technology Co., Ltd. to focus on cutting-edge AI research [2]. - NianKong Technology has fully replaced traditional statistical arbitrage strategies with deep learning-based machine learning algorithms across all its stock strategy products [2]. Group 2: Performance Metrics - NianKong Technology's quantitative products have shown impressive performance, with an average return of ***% over the past year [2]. - Among the 15 billion AI quantitative private equity firms, 13 have reported products with performance data, achieving an average return of 29.91% over the past year [7]. - The average returns for these firms over three years and five years are 41.15% and 117.06%, respectively [7]. Group 3: Industry Trends - The number of billion-dollar quantitative private equity firms in China has reached 39, with 15 actively engaging in AI-related investments [3]. - The trend of integrating AI into quantitative investment strategies has been accelerated since the emergence of DeepSeek, a significant AI model in the industry [4]. - The application of AI technologies is seen as a key factor for survival and competitiveness in the quantitative investment sector [25].

Core Viewpoint - The article emphasizes the power of compound interest and the challenges of achieving consistent positive returns in the current complex market environment, particularly in the A-share market, where the CSI 300 index has shown significant fluctuations since 2021, with a cumulative decline of 27.65% as of April 30, 2025 [2][3]. Summary by Category Market Performance - Since 2021, the CSI 300 index has experienced annual returns of -5.20%, -21.63%, -11.38%, 14.68%, and -4.18%, with only one year showing positive returns [2]. - The cumulative return from 2021 to April 30, 2025, is -27.65%, indicating a challenging environment for private equity funds to achieve consistent positive returns [2]. Private Equity Fund Performance - As of April 2025, among 926 private equity products (excluding pure bond strategies), only 238 products (approximately 25.7%) have achieved positive returns each year since 2021 [3]. - The successful products are nearly evenly split between quantitative (114 products) and non-quantitative (124 products) strategies [3]. Top Performing Products - The top five products with the highest cumulative returns since 2021 are from JiLu Asset, Shanghai Liangyu Private Equity, JiuKun Investment, and Guangzhou Shouzheng Yiqi [4]. - Notable products achieving over ***% returns since 2021 include JiuKun's "JiuKun Day Enjoy CSI 1000 Index Enhanced No. 1" and Liang Kui's "Liang Kui Xiang Shui Lu Mountain No. 5" [4][12]. Strategy Breakdown - In the quantitative strategy category, there are 35 products that have achieved positive returns each year since 2021, with 16 being from large private equity firms [3][13]. - The subjective long-only equity strategy has 37 products with consistent positive returns, with 20 from large private equity firms [13][14]. Multi-Asset and Other Strategies - There are 33 multi-asset strategy products that have shown positive returns each year since 2021, with 6 from large private equity firms [18]. - In the futures and derivatives strategy category, 35 products have achieved positive returns since 2021, with 4 from large private equity firms [24]. - The bond strategy category has 15 products with consistent positive returns, with 1 from a large private equity firm [27]. Overall Trends - A total of 47 large private equity products have achieved positive returns each year since 2021, with a significant representation from subjective long-only equity strategies [31].